Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 351.20
-3.80 (-1.07%)
At close: Oct 23, 2025
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 145 billion as of October 23, 2025. Its market cap has increased by 128.87% in one year.
Market Cap
145.00B
Enterprise Value
142.61B
Revenue
441.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
351.20
Market Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 145.00B, an increase of 1,028.23%. That is a compound annual growth rate of 137.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 145.00B | 88.60% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 438.81B |
| WuXi AppTec | 291.36B |
| Shenzhen Mindray Bio-Medical Electronics | 270.38B |
| Shanghai United Imaging Healthcare | 117.29B |
| Aier Eye Hospital Group | 114.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 111.84B |
| Yunnan Baiyao Group Co.,Ltd | 101.02B |
| Shanghai Fosun Pharmaceutical (Group) | 73.40B |